| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3419 |
| Trial ID | NCT05828225 |
| Disease | Myasthenia Gravis |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis |
| Year | 2023 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | TXB2023006 |
| Cohort 1 | |||||||
|
|||||||